Patterns of abnormal LFTs and their differential diagnosis

Similar documents
Patterns of abnormal LFTs and their differential diagnosis

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

ABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Approach to Abnormal Liver Tests

Hepatology for the Nonhepatologist

A Rational Evidence-based Approach to Abnormal Liver Tests

LFTs: an update A MacGilchrist PLIG meeting 31st January 2019

HEPETIC SYSTEMS BIOCHEMICAL HEPATOCYTIC SYSTEM HEPATOBILIARY SYSTEM RETICULOENDOTHELIAL SYSTEM

Module 1 Introduction of hepatitis

EVALUATION OF ABNORMAL LIVER TESTS

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

IN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST

What are LFTs? What are LFTs? 3/20/2017. Evaluation of Abnormal Liver Chemistry Tests. Transaminases. Alkaline phosphatase.

Laboratory Tests and Diagnostic Procedures in Liver Disease: Adventures in Liverland

Biochemical Investigations in Liver Disease. Dr Roshitha de Silva Department of Pathology Faculty of Medicine University of Kelaniya

Liver disease in 2017: challenges and opportunities

Interpreting Your Tests

Chronic Hepatitis. Andrew Bathgate Chris Bellamy Royal Infirmary of Edinburgh

Approach to the Patient with Liver Disease

4/27/2018. Disclosures LIVER FUNCTION TESTS LIVER FUNCTION TESTS LIVER FUNCTION TESTS APPROACH TO THE PATIENT WITH ABNORMAL LIVER TESTS

Faculty Disclosure. Objectives. Cirrhosis Management for the Family Physician 18/11/2014

What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon

9/28/2016. Elevated Liver Function Tests: A Case Based Approach. Objectives. Identify patterns of abnormal liver function tests

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Abnormal Liver Chemistries. Lauren Myers, MMsc. PA-C Oregon Health and Science University

Liver Network. Guidelines for the Management of Adults with Asymptomatic Liver Function Abnormalities

Disclosure. Evaluation of Abnormal Hepatic Enzymes

MEDIC CENTER. Case 2

Chewing the Fat on Fatty Liver Mike Kolber MD, CCFP, MSc PEIP 2018

Abnormal LFTs in migrant populations. Dr Doug Macdonald Consultant Hepatologist Royal Free Hospital

Mrs Janet Catt. Pre-Conference Nurse s Course. Royal Free London NHS Foundation Trust. Janet Catt MSc RN Lead Nurse Specialist Practic 12/12/2014

ABIM Review Hepatobiliary

Management of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France

Stick or twist management options in hepatitis C

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

ABIM Review Hepatobiliary

Anaemia Pathway. Anaemia. Type of Anaemia Check Haematinics (Iron stores,b12,folate) Fit for endoscopies. endoscopies yes no. Non Iron Deficient

Liver Network Guidelines for the Management of Adults with Asymptomatic Liver Function Abnormalities

Learning Objectives. After attending this presentation, participants will be able to:

Investigating and Referring Incidental Findings of Abnormal Liver Tests

Abnormal LFTs GP CME 2014 Workshop Fri 55 mins. Dr Alasdair Patrick Macmurray Center GP CME 2014

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Chronic Hepatitis B Infection

Hepatology cases for the generalist. Will Gelson Consultant Hepatologist Addenbrooke s Hospital

Test Profiles Time for a Change. Tony Badrick (AACB Harmonisation Committee)

CITY AND HACKNEY CCG ABNORMAL LIVER FUNCTION TESTS (LFTs) in ADULTS

What to do about the high ALT picked up at the annual review. Dr Michael Yee Consultant in Diabetes and Endocrinology

ABIM Review Hepatology

Interpreting Liver Function Tests

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

Liver Pathology Symposium - medical livers

Western Health Specialist Clinics Access & Referral Guidelines

Mikhail Alper, PA-C California Gastroenterology Associates Fresno/Madera, CA. Dr. Robert Gish Dr. Sammy Saab Dr. Naeem Akhtar

Autoimmune Hepatitis in Clinical Practice

World Health Organization. Western Pacific Region

May 2015 CLINICAL REFERENCE. gastroenterology

Mr Ricky Gellissen Imperial College Healthcare NHS Trust, London, UK

Dr Mere Kende. MBBS,Mmed(Path), MAACB, MACTM, MACRRM Lecturer -SMHS

Outline. Updates in the Clinical Management of Hepatitis B and C. Who should be screened for HBV? Chronic Hepatitis B 10/7/2018

New York State HCV Provider Webinar Series. Overview of Fibrosis Staging, Child s Pugh, MELD Scores

Physical Aspects of Substance Misuse in Older People. Jane Collier Consultant Hepatology John Radcliffe Hospital Oxford

Monitoring Hepatitis C

Hepatitis C Virus (HCV)

Liver 102: Injury and Healing

New York State HCV Provider Webinar Series

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis

Steatosis/Steatohepatitis

Catherine Kerschen DO, FACOI Michigan State University College of Osteopathic Medicine

King Abdul-Aziz University Hospital (KAUH) is a tertiary

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Approach to the Patient with Abnormal Liver Enzymes

Interpreting Liver Tests What Do They Mean? Roman E. Perri, MD

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

6/27/2018. Approach to Elevated Liver Tests. At the conclusion the audience should have a better understanding of

Drug therapy in patient with hepatic impairment

ACCME/Disclosures. The Overlap Syndromes: Do They Exist? Key Points and Questions 4/6/2016. Hans Popper Hepatopathology Society

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

CASES FOR DISCUSSION. Yohannes B

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

World Health Organization. Western Pacific Region

Liver Disease. Is it a big problem? Who is affected What causes it What is required. Community Hepatology Practical tips. Change of Tempo & Style

Emerging Challenges In Primary Care: Chronic Hepatitis B: Guidelines for Screening, Clinical Management, Whether to Follow or Treat, and How

Not All Patients With Liver Disease Have HCV Diagnosis and Management of Some Common Non HCV Liver Diseases

Pretreatment Evaluation

Liver Function Testing. in primary care. Quiz Feedback

Pretreatment Evaluation

HEPATOCELLULAR CARCINOMA: AN OVERVIEW

Hepatitis C Pre-Treatment Assessment: The Role of the Primary and HCV Provider

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

King s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know.

LIVER DISEASES. Anatomy

Transcription:

Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth

Outline liver function / liver function tests sources of various liver enzymes patterns of liver enzyme abnormality major causes of abnormal liver function Assess liver disease severity Form a differential diagnosis on the basis of LFTs and limited history

Tests of liver function Synthetic functions: Albumin Clotting factors prothrombin time Excretory function bilirubin

Liver function tests AST and/or ALT alkaline phosphatase (GGT) Bilirubin albumin total protein. ie mostly indicators of liver damage

Interpretation of LFTs AST / ALT hepatocellular enzymes AST mitochondrial ALT cytosolic AST / ALT ratio ALT > AST hepatitis AST > ALT alcohol (or in cirrhosis)

Interpretation of LFTs Alkaline phosphatase biliary epithelium also comes from bone GGT also biliary Alk P GGT - biliary source Obstruction Infiltration congestion Alk Phos GGT normal - think bones Isoenzymes rarely needed

Interpretation of LFTs Albumin Globulin fraction Other tests: PT / INR Alpha foetoprotein (AFP) Full blood count

Causes of chronic liver disease Non-alcoholic fatty liver disease Alcohol Viral Immunological Genetic / Metabolic

Investigation of abnormal LFTs History alcohol, drugs, sex, blood, travel, PMH, FH Viral markers HCV antibody (HCV Ab) Hepatitis B surface antigen (HBsAg) HCV 300,000 cases in UK HBV 180,000 cases in UK

Investigation of abnormal LFTs Immunoglobulins IgG - auto immune hepatitis IgM - primary biliary cirrhosis IgA - alcohol All 3 - cirrhosis Auto antibodies ANA / ASM - auto immune hepatitis (type I) LKM - auto immune hepatitis (type II) AMA - primary biliary cirrhosis ANCA - primary sclerosing cholangitis

Investigation of abnormal LFTs Haemochromatosis Ferritin Consider HFE genotype, transferrin saturation Alpha-1 anti-trypsin deficiency A1AT level (Wilsons disease - copper / caeruloplasmin) Imaging - ultrasound

Chronic liver disease screen: HBsAg HCV Ab Ig s and auto antibodies Ferritin A1AT AFP ± Caeruloplasmin / copper

Liver disease severity: Biochemical Albumin PT Bilirubin Clinical Ascites Hepatic encephalopathy Nutritional status

Child-Pugh score Child Turcotte score 1964 Modified by Pugh 1973 Child-Pugh score Useful predictor of outcomes Death from variceal bleeding Outcomes of surgery in patients with cirrhosis Comparison of patients in different hospitals Pugh RN et al B J Surg 1973;60:646

Child-Pugh score for cirrhosis severity category 1 2 3 Encephalopathy 0 I/II III/IV Ascites Absent Mild / mod Severe Bilirubin <35 35-50 >50 Albumin >35 28-35 <28 PT 1-4 seconds 4-6 seconds >6 seconds Child s A - 6 or less, Child s B - 7-9, Child s C - 10 or more

Pros / cons with C-P score: Very simple Easily calculated Good predictor Subjective measures Ceiling effect ie bili >300, alb 19 scores same as bili 65, alb 26

Other liver severity scores Used in transplant listing decisions MELD INR / bilirubin / creatinine UKELD INR / bilirubin / creatinine / sodium

Case 1 Liver biopsy Miss KM, 21yrs Jaundiced, abn LFTs?cause

Case 1 AST 1287, ALT 1860, Alk P 367, GGT 478, bili 182, alb 35, total protein 73 Hb14.8, WBC 9.7, plts 296, INR1.2 Severe hepatitis with jaundice?viral? Auto-immune??drug toxicity

Case 2 Mr J D Age 49 EtOH++ Abn LFTs? Cause

Case 2 - Mr JD AST 497, ALT 563, Alk P 203 GGT 1378, bili 87, alb 37 Hb15.8, WBC 6.4 plts 296, INR1.2 Hepatitic process with mild jaundice Preserved liver synthetic function AST/ALT wrong AST too high for alcoholic hepatitis Think additional pathology Viral, auto-immune, drugs

Case 3 Mrs SB Age 63 Type II diabetic, overweight no alcohol

Case 3 - Mrs SB ALT 57, AST 84, bili 17, Alb 36, Alk P 107, GGT 167 Hb 13.1, WBC 4.5, Plts 128

Case 3 - Mrs SB ALT 57, AST 84, bili 17, Alb 36, Alk P 107, GGT 167 Hb 13.1, WBC 4.5, Plts 128 Likely diagnosis - NAFLD Concerns?

Case 3 - Mrs SB ALT 57, AST 84, bili 17, Alb 36, Alk P 107, GGT 167 Hb 13.1, WBC 4.5, Plts 128 Likely diagnosis - NAFLD Concerns? AST / ALT wrong -?cirrhotic? Drinking platelets may indicate hypersplenism

Caveats Normal range is set by mean ± 2SD US study suggests ULN ALT 29 for men, 22 for women NHANEs data 3747 adults low risk of liver disease 36.4% of men and 23.8% of women have abnormal LFTs! Hepatology 2012;55:447

Caveats Abnormal LFTs do not always indicate liver disease Normal LFTs do not always exclude liver disease. HCV 1:6 with persistently normal ALT will have significant pathology on liver bx Am J Gastro 2003;98:1588 Clear link between ALT elevation and liver mortality, even for values within the normal range Gastro 2009;136:477 In a community setting >70% with high Fibroscan score had normal LFTs Harman DJ et al BMJ Open 2015

Conclusions Interpreting LFTs useful and easy Most liver diseases can be diagnosed and assessed by blood tests caution with interpreting numbers Liver biopsy still has a useful role

Research Fellow Post NIHR funded 3 year PhD project studying HCC and antitumour vaccination Suit a pathology trainee Please contact me if interested matthew.cramp@nhs.net 01752 432722